Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda ; volume:12 ; number:1 ; day:4 ; month:9 ; year:2012 ; pages:1-9 ; date:12.2012
BMC public health ; 12, Heft 1 (4.9.2012), 1-9, 12.2012
- Creator
-
Sempa, Joseph
- Contributor
-
Ssennono, Mark
Kuznik, Andreas
Lamorde, Mohammed
Sowinski, Stefanie
Semeere, Aggrey
Hermans, Sabine
Castelnuovo, Barbara
Manabe, Yukari C.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-12-736
- URN
-
urn:nbn:de:1111-2016081413461
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sempa, Joseph
- Ssennono, Mark
- Kuznik, Andreas
- Lamorde, Mohammed
- Sowinski, Stefanie
- Semeere, Aggrey
- Hermans, Sabine
- Castelnuovo, Barbara
- Manabe, Yukari C.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018–2021
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia
Konversionsprozesse in Ankole, Uganda : Initiation, Segregation und Aushandlung
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018–2021
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia
Konversionsprozesse in Ankole, Uganda : Initiation, Segregation und Aushandlung
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
Rapid antiretroviral therapy initiation following rollout of point-of-care early infant diagnosis testing, Uganda, 2018–2021
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Long-term virological outcome in children receiving first-line antiretroviral therapy
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study
‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia
Konversionsprozesse in Ankole, Uganda : Initiation, Segregation und Aushandlung
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy